Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

Benzer Materyaller

• Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
  Yazar:: Walther, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
  Yazar:: Vuola, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
  Yazar:: Dunachie, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
  Yazar:: Rodolfo F. Marques, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
  Yazar:: Webster, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)